The WHO’s Solidarity trial examined remdesivir, hydroxychloroquine, and two other drug combos for effectiveness against Covid-19. The WHO’s statement that remdesivir should not be used was ignored by Fauci and the FDA. The WHO’s sabotage of HCQ was used to suppress the life-saving drug in favor of toxic remdesivir, and also to make way for the unnecessary Covid shots.
Fauci, back in April of 2020 couldn't just ignore HCQ, despite his preference for the profitable remdesivir - not with all that "Buzz on the internet." "The buzz" most likely had to do with doctors who were having success treating Covid patients with hydroxychloroquine.
In April 2020 the NIH did a short retrospective study on HCQ, meaning they analyzed the records of a couple hundred men over age 65 in VA hospitals, and found "No evidence that use of hydroxychloroquine, either with or without azithromycin, reduced the risk of mechanical ventilation in patients hospitalized with Covid-19." The analysis also concluded that overall mortality increased in patients treated with HCQ. What the NIH Veterans Administration study failed to point out is that HCQ is most effective at onset of symptoms during the viral replication stage, not when a Covid patient is ill enough to be hospitalized and in the inflammation stage of the disease.
The WHO's multi-nation Solidarity Trial had recently resumed the HCQ arm of the study which they had paused in May 2020 due to the reports from the Surgisphere study published in the Lancet, a premiere medical journal.
Aside from the fact that they were giving HCQ at the wrong point in Covid infection, Dr. Nass was alarmed to learn that both the Solidarity and Recovery trials were administering toxic doses of HCQ to trial participants.
Relying on the skewed results from the Recovery Trial, on June 15, 2020, the FDA revoked its EUA approval of HCQ. The FDA alert stated that "Continued review of the scientific evidence available for hydroxychloroquine sulfateto treat Covid-19" determined that "The potential benefits ofHCQ no longer outweigh the known and potential risks for the authorized use."
Profit motives behind killing HCQ:. With regard to the suppression of HCQ use, Dr. Nass concluded, "WHO and other national health agencies, universities and charities have conducted large clinical trials that were designed so hydroxychloroquine would fail to show benefit in the treatment of Covid-19, perhaps to advantage much more expensive competitors and vaccines in development, which have been heavily supported by Solidarity and Recovery trial sponsors and WHO sponsors."
There's 400 studies that show benefits from hydroxychloroquine and almost 100 studies, I think 99, that show extreme benefitof ivermectin.
No comments:
Post a Comment